Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Development of a New Rapid Diagnostic Test for Onchocerciasis
NCT06350851Completed
- Sponsor
- BIOASTER
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Trial (4 arms), sponsored by BIOASTER. Primary endpoint: Evaluation of the performance of the prototype diagnostic test at 52 weeks. Started Apr 2024; status: completed.
Beyond the preview
Go deeper on NCT06350851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350851.